Cargando…

Recommendations from the ASCO Academic Global Oncology Task Force

In recognition of the rising incidence and mortality of cancer in low- and middle-resource settings, as well as the increasingly international profile of its membership, ASCO has prioritized efforts to enhance its engagement at a global level. Among the recommendations included in the 2016 Global On...

Descripción completa

Detalles Bibliográficos
Autores principales: Gralow, Julie R., Asirwa, Fredrick Chite, Bhatt, Ami Siddharth, Bourlon, Maria T., Chu, Quyen, Eniu, Alexandru E., Loehrer, Patrick J., Lopes, Gilberto, Shulman, Lawrence N., Close, Julia, Von Roenn, Jamie, Tibbits, Michal, Pyle, Doug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713550/
https://www.ncbi.nlm.nih.gov/pubmed/33151772
http://dx.doi.org/10.1200/GO.20.00497
_version_ 1783618583445635072
author Gralow, Julie R.
Asirwa, Fredrick Chite
Bhatt, Ami Siddharth
Bourlon, Maria T.
Chu, Quyen
Eniu, Alexandru E.
Loehrer, Patrick J.
Lopes, Gilberto
Shulman, Lawrence N.
Close, Julia
Von Roenn, Jamie
Tibbits, Michal
Pyle, Doug
author_facet Gralow, Julie R.
Asirwa, Fredrick Chite
Bhatt, Ami Siddharth
Bourlon, Maria T.
Chu, Quyen
Eniu, Alexandru E.
Loehrer, Patrick J.
Lopes, Gilberto
Shulman, Lawrence N.
Close, Julia
Von Roenn, Jamie
Tibbits, Michal
Pyle, Doug
author_sort Gralow, Julie R.
collection PubMed
description In recognition of the rising incidence and mortality of cancer in low- and middle-resource settings, as well as the increasingly international profile of its membership, ASCO has prioritized efforts to enhance its engagement at a global level. Among the recommendations included in the 2016 Global Oncology Leadership Task Force report to the ASCO Board of Directors was that ASCO should promote the recognition of global oncology as an academic field. The report suggested that ASCO could serve a role in transitioning global oncology from an informal field of largely voluntary activities to a more formal discipline with strong research and well-defined training components. As a result of this recommendation, in 2017, ASCO formed the Academic Global Oncology Task Force (AGOTF) to guide ASCO’s contributions toward formalizing the field of global oncology. The AGOTF was asked to collect and analyze key issues and barriers toward the recognition of global oncology as an academic discipline, with an emphasis on training, research, and career pathways, and produce a set of recommendations for ASCO action. The outcome of the AGOTF was the development of recommendations designed to advance the status of global oncology as an academic discipline.
format Online
Article
Text
id pubmed-7713550
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-77135502020-12-04 Recommendations from the ASCO Academic Global Oncology Task Force Gralow, Julie R. Asirwa, Fredrick Chite Bhatt, Ami Siddharth Bourlon, Maria T. Chu, Quyen Eniu, Alexandru E. Loehrer, Patrick J. Lopes, Gilberto Shulman, Lawrence N. Close, Julia Von Roenn, Jamie Tibbits, Michal Pyle, Doug JCO Glob Oncol SPECIAL ARTICLES In recognition of the rising incidence and mortality of cancer in low- and middle-resource settings, as well as the increasingly international profile of its membership, ASCO has prioritized efforts to enhance its engagement at a global level. Among the recommendations included in the 2016 Global Oncology Leadership Task Force report to the ASCO Board of Directors was that ASCO should promote the recognition of global oncology as an academic field. The report suggested that ASCO could serve a role in transitioning global oncology from an informal field of largely voluntary activities to a more formal discipline with strong research and well-defined training components. As a result of this recommendation, in 2017, ASCO formed the Academic Global Oncology Task Force (AGOTF) to guide ASCO’s contributions toward formalizing the field of global oncology. The AGOTF was asked to collect and analyze key issues and barriers toward the recognition of global oncology as an academic discipline, with an emphasis on training, research, and career pathways, and produce a set of recommendations for ASCO action. The outcome of the AGOTF was the development of recommendations designed to advance the status of global oncology as an academic discipline. American Society of Clinical Oncology 2020-11-05 /pmc/articles/PMC7713550/ /pubmed/33151772 http://dx.doi.org/10.1200/GO.20.00497 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle SPECIAL ARTICLES
Gralow, Julie R.
Asirwa, Fredrick Chite
Bhatt, Ami Siddharth
Bourlon, Maria T.
Chu, Quyen
Eniu, Alexandru E.
Loehrer, Patrick J.
Lopes, Gilberto
Shulman, Lawrence N.
Close, Julia
Von Roenn, Jamie
Tibbits, Michal
Pyle, Doug
Recommendations from the ASCO Academic Global Oncology Task Force
title Recommendations from the ASCO Academic Global Oncology Task Force
title_full Recommendations from the ASCO Academic Global Oncology Task Force
title_fullStr Recommendations from the ASCO Academic Global Oncology Task Force
title_full_unstemmed Recommendations from the ASCO Academic Global Oncology Task Force
title_short Recommendations from the ASCO Academic Global Oncology Task Force
title_sort recommendations from the asco academic global oncology task force
topic SPECIAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713550/
https://www.ncbi.nlm.nih.gov/pubmed/33151772
http://dx.doi.org/10.1200/GO.20.00497
work_keys_str_mv AT gralowjulier recommendationsfromtheascoacademicglobaloncologytaskforce
AT asirwafredrickchite recommendationsfromtheascoacademicglobaloncologytaskforce
AT bhattamisiddharth recommendationsfromtheascoacademicglobaloncologytaskforce
AT bourlonmariat recommendationsfromtheascoacademicglobaloncologytaskforce
AT chuquyen recommendationsfromtheascoacademicglobaloncologytaskforce
AT eniualexandrue recommendationsfromtheascoacademicglobaloncologytaskforce
AT loehrerpatrickj recommendationsfromtheascoacademicglobaloncologytaskforce
AT lopesgilberto recommendationsfromtheascoacademicglobaloncologytaskforce
AT shulmanlawrencen recommendationsfromtheascoacademicglobaloncologytaskforce
AT closejulia recommendationsfromtheascoacademicglobaloncologytaskforce
AT vonroennjamie recommendationsfromtheascoacademicglobaloncologytaskforce
AT tibbitsmichal recommendationsfromtheascoacademicglobaloncologytaskforce
AT pyledoug recommendationsfromtheascoacademicglobaloncologytaskforce